FBRX (Forte Biosciences, Inc.) Stock Market Reviews

crown

search

Read and share opinions on FBRX (Forte Biosciences, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

FBRX

Forte Biosciences, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
Nov 14, 2025
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
Oct 3, 2025
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
Sep 15, 2025
This Forte Biosciences Insider Increased Their Holding By 273% Last Year
Aug 15, 2025
Forte Biosciences, Inc. Announces Results and Provides Update
Aug 14, 2025
Forte Biosciences Announces Pricing of $75 Million Public Offering
Jun 25, 2025
Forte Biosciences Announces Proposed Public Offering
Jun 24, 2025
Forte Biosciences announces data from trial in celiac disease for FB102
Jun 24, 2025
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
Jun 23, 2025
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
Mar 31, 2025
One Forte Biosciences Insider Raised Stake By 273% In Previous Year
Feb 19, 2025
Forte Biosciences to Host R&D Day December 3, 2024
Nov 25, 2024
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
Nov 20, 2024

Reviews